CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (CLDI)

Q: What does CUSIP 320703309 represent in this 13F holders report?

CUSIP 320703309 is the security identifier for CLDI - CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CLDI - CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share in Q1 2025?

35 institutional investors reported CLDI - CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 320703309

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common stock, par value $0.0001 per share
Shares outstanding: 11,128,448
Total 13F shares: 5,458,730
Share change: +4,365,301
Total reported value: $3,091,541
Reported price per share: $0.57
Number of holders: 35
Value change: +$2,351,586
Number of buys: 17
Number of sells: 10

Security key

320703309

Report period

Q1 2025

Institutions

Top holders

CLDI full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2025 Previous quarter: Q4 2024 Calidi Biotherapeutics, Inc. SEC filings Calidi Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 320703309

Newer quarter: Q2 2025 Previous quarter: Q4 2024

Recent filing periods:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of CLDI - CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

GEODE CAPITAL MANAGEMENT,...

13D/G signal

—

Evidence rows

Latest as of

31 Dec 2024

13F 3/4/5 Lead comparable stake: 1.4% Showing 1-8 of 46 holder rows.

Rank 1 holder

GEODE CAPITAL MANAGEMENT, LLC

13F

Ownership: 1.4%
Position: $184K

13F

Rank 2 holder

MILLENNIUM MANAGEMENT LLC

13F

Ownership: 1.2%
Position: $156.6K

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	1.4%	$184,019 160,018 shares	—	31 Dec 2024
MILLENNIUM MANAGEMENT LLC	13F Company 13F	1.2%	$156,558 136,137 shares	—	31 Dec 2024
HighTower Advisors, LLC	13F Company 13F	0.92%	$117,617 102,276 shares	—	31 Dec 2024
CPR Investments Inc.	13F Company 13F	0.91%	$116,150 101,000 shares	—	31 Dec 2024
DRIVE WEALTH MANAGEMENT, LLC	13F Company 13F	0.81%	$103,500 90,000 shares	—	31 Dec 2024
Red Wave Investments LLC	13F Company 13F	0.73%	$92,952 80,828 shares	—	31 Dec 2024
Virtu Financial LLC	13F Company 13F	0.66%	$84,000 73,448 shares	—	31 Dec 2024
VANGUARD GROUP INC	13F Company 13F	0.55%	$70,580 61,374 shares	—	31 Dec 2024

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

5,458,730

Rows loaded

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders

Q1 2025 holders

Holder diff

Investor	Q4 2024 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q4 2024 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend